HIV: Cell Binding and Entry

Cited by (658)

Items 301–400 of 658

1. Viruses Utilize Cellular Cues in Distinct Combination to Undergo Systematic Priming and Uncoating
   Madhu Sudhan Ravindran, Billy Tsai · 2016 · PLoS Pathogens
2. Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5
   Guiqing Hu, Jun Liu, Kenneth H. Roux, Kenneth A. Taylor · 2017 · Journal of Virology
3. Structural Transition and Antibody Binding of EBOV GP and ZIKV E Proteins from Pre-Fusion to Fusion-Initiation State
   Anna Lappala, Wataru Nishima, Jacob C. Miner, Paul W. Fenimore, Will Fischer, Peter Hraber, Ming Zhang, Benjamin H. McMahon, Chang‐Shung Tung · 2018 · Biomolecules
4. HIV X4 Variants Increase Arachidonate 5-Lipoxygenase in the Pulmonary Microenvironment and are associated with Pulmonary Arterial Hypertension
   Sharilyn Almodóvar, Brandy E. Wade, Kristi Michelle Porter, Justin M. Smith, Robert A. López-Astacio, Kaiser M. Bijli, Bum‐Yong Kang, Sushma K. Cribbs, David M. Guidot, Deborah Molehin et al. · 2020 · Scientific Reports
5. Virus-Induced Cell Fusion and Syncytia Formation
   Maorong Xie · 2023 · Results and problems in cell differentiation
6. Beyond bNAbs: Uses, Risks, and Opportunities for Therapeutic Application of Non-Neutralising Antibodies in Viral Infection
   Kahlio Mader, Lynn B. Dustin · 2024 · Antibodies
7. Fatty acid conjugated EPI-X4 derivatives with increased activity and in vivo stability
   Mirja Harms, André Haase, Armando Rodríguez, Jessica Löffler, Yasser Almeida‐Hernández, Yasser B. Ruiz‐Blanco, Dan Albers, Andrea Gilg, Franziska von Bank, Fabian Zech et al. · 2024 · Journal of Controlled Release
8. Small-molecule HIV-1 entry inhibitors targeting the epitopes of broadly neutralizing antibodies
   Shibo Jiang, Alexander V. Tuzikov, Alexander M. Andrianov · 2022 · Cell chemical biology
9. Efficient removal of anti-HIV drug - maraviroc from natural water by peroxymonosulfate and TiO2 photocatalytic oxidation: Kinetic studies and identification of transformation products
   Jakub Trawiński, Michał Wroński, Robert Skibiński · 2022 · Journal of Environmental Management
10. Extracellular vesicle isolation methods identify distinct HIV‐1 particles released from chronically infected T‐cells
    Sebastian Molnar, Yuriy Kim, Lindsay Wieczorek, Anastasia Williams, Kajal Patil, Pooja Khatkar, Mark F. Santos, Gifty A. Mensah, Aurelio Lorico, Victoria R. Polonis et al. · 2024 · Journal of Extracellular Vesicles
11. Modern biotechnology-based therapeutic approaches against HIV infection (Review)
    Muhammad Imran, Yasir Waheed, Ayesha Ghazal, Sajjad Ullah, Sher Zaman Safi, Muhsin Jamal, Muhammad Ali, Muhammad Atif, Muhammad Imran, Farman Ullah · 2017 · Biomedical Reports
12. Hormonal influence on HIV ‐1 transmission in the female genital tract: New insights from systems biology
    Haley A. Dupont, Jeff Lam, Matthew William Woods, Muhammad Atif Zahoor, Charu Kaushic · 2018 · American Journal of Reproductive Immunology
13. Influenza – A new pathogen every year
    Rodrigo B. Abreu, Ted M. Ross · 2018 · Current Opinion in Systems Biology
14. Replicating Adenovirus-SIV Immunization of Rhesus Macaques Induces Mucosal Dendritic Cell Activation and Function Leading to Rectal Immune Responses
    Eun‐Ju Ko, Sabrina Helmold Hait, Gospel M Enyindah-Asonye, Mohammad Arif Rahman, Tanya N. Hoang, Marjorie Robert-Guroff · 2019 · Frontiers in Immunology
15. Species-Specific Valid Ternary Interactions of HIV-1 Env-gp120, CD4, and CCR5 as Revealed by an Adaptive Single-Amino Acid Substitution at the V3 Loop Tip
    Takaaki Koma, Masaru Yokoyama, Osamu Kotani, Naoya Doi, Nina Nakanishi, Hayato Okubo, Shun Adachi, Akio Adachi, Hironori Sato, Masako Nomaguchi · 2021 · Journal of Virology
16. Application of Nanotechnology in the Treatment of Infectious Diseases: An Overview
    Ifeanyi Elibe Mba, Emeka Innocent Nweze · 2022 · Springer eBooks
17. A cellular trafficking signal in the SIV envelope protein cytoplasmic domain is strongly selected for in pathogenic infection
    Scott P. Lawrence, Samra E. Elser, Workineh Torben, Robert V. Blair, Bapi Pahar, Pyone P. Aye, Faith R. Schiro, Dawn M. Szeltner, Lara A. Doyle‐Meyers, Beth Haggarty et al. · 2022 · PLoS Pathogens
18. Human Endogenous Retrovirus, SARS-CoV-2, and HIV Promote PAH via Inflammation and Growth Stimulation
    Desheng Wang, Marta Teixeira Gomes, Yanfei Mo, Clare C. Prohaska, Lu Zhang, Sarvesh Chelvanambi, Matthias A. Clauss, Dongfang Zhang, Roberto F. Machado, Mingqi Gao et al. · 2023 · International Journal of Molecular Sciences
19. Peptide-Induced Fusion of Dynamic Membrane Nanodomains: Implications in a Viral Entry
    Anurag Chaudhury, Shovon Swarnakar, Gourab Prasad Pattnaik, Gopal Kishor Varshney, Hirak Chakraborty, J. K. Basu · 2023 · Langmuir
20. Anti HIV-1 Activity of the Crude Extracts of Guaiacum officinale L. (Zygophyllaceae)
    Henry I. C. Lowe · 2014 · European Journal of Medicinal Plants
21. Evolution of coreceptor utilization to escape CCR5 antagonist therapy
    Jie Zhang, Xiang Gao, John C Martin, Bruce A. Rosa, Zheng Chen, Makedonka Mitreva, Timothy J. Henrich, Daniel R. Kuritzkes, Lee Ratner · 2016 · Virology
22. Human Immunodeficiency Virus I: History, Epidemiology, Transmission, and Pathogenesis
    Bradford Becken, Ami Multani, Simi Padival, Coleen K. Cunningham · 2019 · Springer eBooks
23. A screening for DNA damage response molecules that affect HIV-1 infection
    Noriyoshi Yoshinaga, Keisuke Shindo, Yusuke Matsui, Yoko Takiuchi, Hirofumi Fukuda, Kayoko Nagata, Kotaro Shirakawa, Masayuki Kobayashi, Shunichi Takeda, Akifumi Takaori‐Kondo · 2019 · Biochemical and Biophysical Research Communications
24. Lack of susceptibility in neonatally infected rhesus macaques to simian immunodeficiency virus-induced encephalitis
    Elizabeth Delery, Diana G. Bohannon, Derek L. Irons, Carolina Allers, Chie Sugimoto, Yanhui Cai, Kristen M. Merino, Angela M. Amedee, Ronald S. Veazey, Andrew G. MacLean et al. · 2019 · Journal of NeuroVirology
25. Mannose Derivatives as Anti-Infective Agents
    Rosana Ribić · 2025 · International Journal of Molecular Sciences
26. Six-helix bundle completion in the distal C-terminal heptad repeat region of gp41 is required for efficient human immunodeficiency virus type 1 infection
    Dehua Liu, Hongyun Wang, Mizuki Yamamoto, Jiping Song, Rui Zhang, Qingling Du, Yasushi Kawaguchi, Jun‐ichiro Inoue, Zene Matsuda · 2018 · Retrovirology
27. Structure-Based Identification of Natural-Product-Derived Compounds with Potential to Inhibit HIV-1 Entry
    Nneka Ugwu-Korie, Osbourne Quaye, Edward Wright, Sylvester Languon, Odame Agyapong, Emmanuel Broni, Yash A. Gupta, Prakasha Kempaiah, Samuel K. Kwofie · 2023 · Molecules
28. Ethnopharmacological Potential of Phytochemicals and Phytogenic Products against Human RNA Viral Diseases as Preventive Therapeutics
    Anamika Paul, Nilanjan Chakraborty, Anik Sarkar, Krishnendu Acharya, Anuj Ranjan, Abhishek Pratap Singh Chauhan, Shilpi Srivastava, Akhilesh Kumar Singh, Ashutosh Kumar, Iqra Mubeen et al. · 2023 · BioMed Research International
29. Challenges in HIV-1 Latent Reservoir and Target Cell Quantification in CAR-T Cell and Other Lentiviral Gene Modifying HIV Cure Strategies
    Amanda M. Buck, Tyler‐Marie Deveau, Timothy J. Henrich, Amelia N. Deitchman · 2023 · Viruses
30. Modulation of the Fibrillation Kinetics and Morphology of a Therapeutic Peptide by Cucurbit[7]uril
    Marcello Martinez Morales, Christopher F. van der Walle, Jeremy P. Derrick · 2023 · Molecular Pharmaceutics
31. Applying Flow Virometry to Study the HIV Envelope Glycoprotein and Differences Across HIV Model Systems
    Jonathan Burnie, Claire Fernandes, Ayushi Patel, Arvin Tejnarine Persaud, Deepa Chaphekar, Danlan Wei, Timothy Kit Hin Lee, Vera A. Tang, Claudia Cicala, James A. Arthos et al. · 2024 · Viruses
32. Plant-Derived Molecules in Managing HIV Infection
    Jay S. Trivedi, Anjali Tripathi, Debprasad Chattopadhyay, Debashis Mitra · 2018 · Elsevier eBooks
33. Altered Env conformational dynamics as a mechanism of resistance to peptide-triazole HIV-1 inactivators
    Shiyu Zhang, Andrew P. Holmes, Alexej Dick, Adel Ahmed Rashad, Lucía Enríquez, Gabriela Canziani, Michael J. Root, IRWIN M. CHAIKEN · 2021 · Retrovirology
34. Synthesis and Evaluation of Novel Tetrahydronaphthyridine CXCR4 Antagonists with Improved Drug-like Profiles
    Edgars Jēčs, Yesim A. Tahirovic, Robert J. Wilson, Eric J. Miller, Michelle H. Kim, Valarie M. Truax, Huy Hoang Nguyen, Nicholas S. Akins, Manohar Saindane, Tao Wang et al. · 2022 · Journal of Medicinal Chemistry
35. HIV-1–Infected CD4+ T Cells Present MHC Class II–Restricted Epitope via Endogenous Processing
    Mary M. Addison, Gavin I. Ellis, George J. Leslie, Noah B. Zawadzky, James L. Riley, James A. Hoxie, Laurence Crane Eisenlohr · 2022 · The Journal of Immunology
36. Computational identification of novel entry inhibitor scaffolds mimicking primary receptor CD4 of HIV-1 gp120
    Alexander M. Andrianov, Ivan A. Kashyn, Alexander V. Tuzikov · 2017 · Journal of Molecular Modeling
37. Bamboo-Inspired Materials and Structures
    Ting Tan, Winston Oluwole Soboyejo · 2020 · Cambridge University Press eBooks
38. Flying of Insects
    Bo Cheng · 2020 · Cambridge University Press eBooks
39. Petiveria alliacea L (Guinea Hen Weed) and Its Major Metabolite Dibenzyl Trisulfide Demonstrate HIV-1 Reverse Transcriptase Inhibitory Activity
    Henry I. C. Lowe, Ngeh J. Toyang, Alonso Heredia, Kenneth Ayeah, Charah T. Watson, Joseph Bryant · 2014 · European Journal of Medicinal Plants
40. HIV-1 and Its Resistance to Peptidic Carbohydrate-Binding Agents (CBAs): An Overview
    Geoffrey Férir, Stephanie C. Gordts, Dominique Schols · 2014 · Molecules
41. The Involvement of Ubiquitination and SUMOylation in Retroviruses Infection and Latency
    Taizhen Liang, Guojie Li, Yunfei Lu, Meilin Hu, Xiancai Ma · 2023 · Viruses
42. Genomic Exploration of the Brain in People Infected with HIV—Recent Progress and the Road Ahead
    Amara L. Plaza-Jennings, Schahram Akbarian · 2023 · Current HIV/AIDS Reports
43. Glutathione in HIV-Associated Neurocognitive Disorders
    Thomas Erdos, Mika Masuda, Vishwanath Venketaraman · 2024 · Current Issues in Molecular Biology
44. A comprehensive identification-evidence based alternative for HIV/AIDS treatment with HAART in the healthcare industries
    You‐Shyang Chen · 2016 · Computer Methods and Programs in Biomedicine
45. HIV Antivirals: Targeting the Functional Organization of the Lipid Envelope
    Pablo Carravilla, Jose Luis Nieva · 2018 · Future Virology
46. HIV and the Antiviral Role of Mushroom Nutraceuticals
    Tito Horácio Fernandes, Eusébio Chaquisse, Jorge Ferrão · 2020 · European journal of applied sciences
47. Peptide Triazole Inhibitors of HIV-1: Hijackers of Env Metastability
    Erik P. Carter, Charles Gotuaco Ang, IRWIN M. CHAIKEN · 2022 · Current Protein and Peptide Science
48. SERINC5-Mediated Restriction of HIV-1 Infectivity Correlates with Resistance to Cholesterol Extraction but Not with Lipid Order of Viral Membrane
    Gokul Raghunath, Yen-Cheng Chen, Mariana Marin, Hui Wu, Gregory B. Melikyan · 2022 · Viruses
49. Discovery of Bis-Imidazoline Derivatives as New CXCR4 Ligands
    Zhicheng Zhou, Isabelle Staropoli, Anne Brelot, Peggy Suzanne, Aurélien Lesnard, Fanny Fontaine, Serge Perato, Sylvain Rault, Olivier Helynck, Fernando Arenzana‐Seisdedos et al. · 2023 · Molecules
50. Help or Hinder: Protein Host Factors That Impact HIV-1 Replication
    Michael Rameen Moezpoor, Mario Stevenson · 2024 · Viruses
51. Exclusive Decoration of Simian Immunodeficiency Virus Env with High-Mannose Type N-Glycans Is Not Compatible with Mucosal Transmission in Rhesus Macaques
    Christina B. Karsten, Falk F. R. Buettner, Samanta Cajic, Inga Nehlmeier, Berit Neumann, Antonina Klippert, Ulrike Sauermann, Udo Reichl, Rita Gerardy‐Schahn, Erdmann Rapp et al. · 2015 · Journal of Virology
52. A Coreceptor-Mimetic Peptide Enhances the Potency of V3-Glycan Antibodies
    Ina Fetzer, Meredith E. Davis-Gardner, Matthew R. Gardner, Barnett Alfant, Jesse A. Weber, Neha R. Prasad, Amber S. Zhou, Michael Farzan · 2018 · Journal of Virology
53. INVASIVE CERVICAL CANCER IN IBADAN: SOCIO-SEXUAL CHARACTERISTICS, CLINICAL STAGE AT PRESENTATION, HISTOPATHOLOGY DISTRIBUTIONS AND HIV STATUS.
    Olutosin Alaba Awolude, Sunday Oladimeji Oyerinde · 2019 · Europe PMC (PubMed Central)
54. The Examination of Viral Characteristics of HIV-1 CRF07_BC and Its Potential Interaction with Extracellular Galectin-3
    C. C. Lin, Wen‐Hung Wang, Szu‐Wei Huang, Chun‐Sheng Yeh, Ruei-Yu Yuan, Zih‐Syuan Yang, Aspiro Nayim Urbina, Sung‐Pin Tseng, Po‐Liang Lu, Yen‐Hsu Chen et al. · 2020 · Pathogens
55. E-pharmacophore based screening to identify potential HIV-1 gp120 and CD4 interaction blockers for wild and mutant types
    Ishwar Chandra, Sitrarasu Vijaya Prabhu, Chirasmita Nayak, Sanjeev Kumar Singh · 2021 · SAR and QSAR in environmental research
56. Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application
    Chengchao Ding, Darshit Patel, Yunjing Ma, Jamie F. S. Mann, Jianjun Wu, Yong Gao · 2021 · Frontiers in Immunology
57. Anti-HIV lectins and current delivery strategies
    Fohona S. Coulibaly, Danielle N. Thomas, Bi-Botti Celestin Youan · 2018 · AIMS molecular science
58. HIV-1 Env-Dependent Cell Killing by Bifunctional Small-Molecule/Peptide Conjugates
    Althea Gaffney, Aakansha Nangarlia, Charles Gotuaco Ang, Steven T. Gossert, Adel Ahmed Rashad, Md. Alamgir Hossain, Cameron F. Abrams, Amos B. Smith, IRWIN M. CHAIKEN · 2021 · ACS Chemical Biology
59. Retroactivism and futurity in 120 BPM and Théo et Hugo
    Chase Ledin · 2021 · Modern & Contemporary France
60. Comparing methods to detect cellular proteins on the surface of HIV-1 virions
    Deepa Chaphekar, Claire Fernandes, Arvin Tejnarine Persaud, Christina Guzzo · 2024 · Journal of Virological Methods
61. Vimentin—a potential biomarker for therapeutic efficiency of HAART
    Xiaofang Jia, Li Liu, Xiaoqian Liu, Dage Wu, Lin Yin, Xiaohui Liu, Jiaoli Zhang, Pengyuan Yang, Hongzhou Lu, Lijun Zhang · 2014 · Acta Biochimica et Biophysica Sinica
62. Cellular Determinants of HIV Persistence on Antiretroviral Therapy
    Anastassia Mikhailova, José Carlos Valle‐Casuso, Asier Sáez‐Cirión · 2018 · Advances in experimental medicine and biology
63. Biological role of miRNA-146a at virus infections. Modern strategy of search of new safe pharmacological agents for treatment
    Petr Dmitrievich Shabanov, Ващенко Владимир Иванович · 2021 · Reviews on Clinical Pharmacology and Drug Therapy
64. Dendritic Cells - Winning the Fight against HIV
    Mohsen Sheykhhasan, Naresh Poondla, Yaghoub Ahmadyousefi, Mohammad Akbari, Reihaneh Seyedebrahimi, Mohsen Eslami Farsani, Naser Kalhor · 2022 · Current Stem Cell Research & Therapy
65. Cost-effective high-speed, three-dimensional live-cell imaging of HIV-1 transfer at the T cell virological synapse
    Alice Sandmeyer, Lili Wang, Wolfgang Hübner, Marcel W. Muller, Benjamin K. Chen, Thomas R. Huser · 2022 · iScience
66. Identification of host receptors for viral entry and beyond: a perspective from the spike of SARS-CoV-2
    Xuhua Xia · 2023 · Frontiers in Microbiology
67. The Evolving HIV-1 Epidemic in Warao Amerindians Is Dominated by an Extremely High Frequency of CXCR4-Utilizing Strains
    Hector Rafael Rangel, Gonzalo Bello, Julian A. Villalba, Yoneira Fabiola Sulbarán, Domingo José Garzaro, Mailis Maes, Carmen Luisa Loureiro, Jacobus Henri de Waard, Flor Helene Pujol · 2015 · AIDS Research and Human Retroviruses
68. Quantifying the Sensitivity of HIV-1 Viral Entry to Receptor and Coreceptor Expression
    Bhaven A. Mistry, Maria Rita D'Orsogna, Nicholas E. Webb, Benhur Lee, Tom Chou · 2016 · The Journal of Physical Chemistry B
69. Frequency and Env determinants of HIV-1 subtype C strains from antiretroviral therapy-naive subjects that display incomplete inhibition by maraviroc
    Katharina Borm, Martin R. Jakobsen, Kieran Cashin, Jacqueline K. Flynn, Paula C. Ellenberg, Lars Jørgen Østergaard, Benhur Lee, Melissa J. Churchill, Michael Roche, Paul R. Gorry · 2016 · Retrovirology
70. Investigating the role of hypothetical protein (AAB33144.1) in HIV-1 virus pathogenicity: A comparative study with FDA-Approved inhibitor compounds through In silico analysis and molecular docking
    Md. Imran Hossain, Anika Tabassum Asha, Md. Arju Hossain, Shahin Mahmud, Kamal Chowdhury, Ramisa Binti Mohiuddin, Nazneen Nahar, Saborni Sarker, Suhaimi B. Napis, Md Sanower Hossain et al. · 2023 · Heliyon
71. A SDF1 genetic variant confers resistance to HIV-1 infection in intravenous drug users in China
    Xiaohong Gong, Yanyan Liu, Feng‐Liang Liu, Jin Li, Hongyan Wang, Yong‐Tang Zheng · 2015 · Infection Genetics and Evolution
72. The crystal structure of HIV CRF07 B′/C gp41 reveals a hyper-mutant site in the middle of HR2 heptad repeat
    Jiansen Du, Hailing Xue, Jing Ma, Fang Liu, Jianhua Zhou, Yiming Shao, Wentao Qiao, Xinqi Liu · 2013 · Virology
73. Retrovirus Receptor Interactions and Entry
    Lorraine M. Albritton · 2018 · Elsevier eBooks
74. Design of gp120 HIV-1 entry inhibitors by scaffold hopping via isosteric replacements
    Ildar R. Iusupov, Francesca Curreli, Evgeniy A. Spiridonov, Pavel O. Markov, Shahad Ahmed, Dmitry S. Belov, Ekaterina V. Manasova, Andrea Altieri, Alexander V. Kurkin, Asim Kumar Debnath · 2021 · European Journal of Medicinal Chemistry
75. Quaternary Interaction of the HIV-1 Envelope Trimer with CD4 and Neutralizing Antibodies
    Qingbo Liu, Peng Zhang, Paolo Lusso · 2021 · Viruses
76. Analysis of Social and Genetic Factors Influencing Heterosexual Transmission of HIV within Serodiscordant Couples in the Henan Cohort
    Qian Zhu, Peng Zhu, Yilei Zhang, Jie Li, Xuejun Ma, Ning Li, Qi Wang, Xiujuan Xue, Le Luo, Zizhao Li et al. · 2015 · PLoS ONE
77. Interaction of viral oncogenic proteins with the Wnt signaling pathway.
    Sayyad Khanizadeh, Banafsheh Hasanvand, Hamed Esmaeil Lashgarian, Mohammad Almasian, Gholamreza Goudarzi · 2018 · Europe PMC (PubMed Central)
78. A Modified ACE2 peptide mimic to block SARS-CoV2 entry
    Suman Saurabh, Shubh Sanket Purohit · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
79. Standard Gibbs Energy of Binding of the gp120 Antigen of HIV-1 to the CD4 Receptor
    Marko E. Popovic · 2022 · Preprints.org
80. Altered Host microRNAomics in HIV Infections: Therapeutic Potentials and Limitations
    Maria J. Santiago, Srinivasan Chinnapaiyan, Kingshuk Panda, Md. Sohanur Rahman, Suvankar Ghorai, Irfan Rahman, Stephen M. Black, Yuan Liu, Hoshang Jehangir Unwalla · 2024 · International Journal of Molecular Sciences
81. Quantifying Impact of HIV Receptor Surface Density Reveals Differences in Fusion Dynamics of HIV Strains
    Anthony Gerg, H. Dobrovolny · 2025 · Viruses
82. Integrative Computational Approaches for Understanding Drug Resistance in HIV-1 Protease Subtype C
    Sankaran Venkatachalam, Nisha Harur Muralidharan, Ramesh Pandian, Yasien Sayed, M. Michael Gromiha · 2025 · Viruses
83. Investigating the Impact of Cholesterol on GP41-Driven HIV Membrane Fusion
    Janmejay Soni, Taraknath Mandal · 2025 · Journal of Chemical Theory and Computation
84. Nuclear pore passage of the HIV capsid is driven by its unusual surface amino acid composition
    Liran Fu, Shiya Cheng, Dietmar Riedel, Leonie Kopecny, Melina Schuh, Dirk Görlich · 2025 · Nature Structural & Molecular Biology
85. On the role of membrane embedding, protein rigidity and transmembrane length in lipid membrane fusion
    Marco van Tilburg, P.A.J. Hilbers, Albert Jan Markvoort · 2023 · Soft Matter
86. Interleukin-27-induced HIV-resistant dendritic cells suppress reveres transcription following virus entry in an SPTBN1, autophagy, and YB-1 independent manner
    Tomozumi Imamichi, Qian Chen, Bharatwaj Sowrirajan, Jun Yang, Sylvain Laverdure, Mayra Marquez, Anthony R. Mele, Catherine Watkins, Joseph W. Adelsberger, Jeanette M. Higgins et al. · 2023 · PLoS ONE
87. Virus–Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid Assays
    Laura Corneillie, Irma H. Lemmens, Karin Weening, Amse De Meyer, Freya Van Houtte, Jan H. Tavernier, Philip Meuleman · 2023 · Viruses
88. Multiple treatment interruptions and protecting HIV-specific CD4 T cells enable durable CD8 T cell response and viral control
    Anshika Jain, Gaspar E. Cánepa, Mei-Ling Liou, Emily L. Fledderman, Andrei I. Chapoval, Lingzhi Xiao, Ipsita Mukherjee, Bushirat M. Balogun, Hellen Huaman-Vergara, Jeffrey A. Galvin et al. · 2024 · Frontiers in Medicine
89. Fullerene (C60 & C70)‐Meso‐Tris‐4‐Carboxyphenyl Porphyrin Dyads Inhibit Entry of Wild‐Type and Drug‐Resistant HIV‐1 Clades B and C
    Debdulal Sharma, Madhu Rai, Aradhana Singh, Ritu Gaur, Devashish Sengupta · 2025 · Journal of Medical Virology
90. The Membrane-Proximal Region of C–C Chemokine Receptor Type 5 Participates in the Infection of HIV-1
    Yue Tan, Pei Tong, Junyi Wang, Lei Zhao, Jing Li, Yang Yu, Yinghua Chen, Ji Wang · 2017 · Frontiers in Immunology
91. Transmission patterns of HIV-1 non-R5 strains in Poland
    Joanna Smoleń‐Dzirba, Magdalena Rosińska, Piotr Kruszyński, Janusz Janiec, Mariusz Cycoń, Jolanta Bratosiewicz‐Wąsik, Marek Beniowski, Monika Bociąga‐Jasik, Elżbieta Jabłonowska, Bartosz Szetela et al. · 2019 · Scientific Reports
92. Selection and immune recognition of HIV-1 MPER mimotopes
    Lindsay Wieczorek, Kristina K. Peachman, Nicholas J. Steers, Jesse Schoen, Mangala Rao, Victoria R. Polonis, Venigalla Basaveswara Rao · 2020 · Virology
93. Temsavir Modulates HIV-1 Envelope Conformation by Decreasing Its Proteolytic Cleavage
    Marianne Boutin, Halima Medjahed, Manon Nayrac, Rishikesh Lotke, Gabrielle Gendron‐Lepage, Catherine Bourassa, Daniel Sauter, Jonathan Richard, Andrés Finzi · 2023 · Viruses
94. Efficient SARS-CoV-2 variant detection and monitoring with Spike Screen next-generation sequencing
    Alen Suljič, Tomaž Mark Zorec, Samo Zakotnik, Doroteja Vlaj, Rok Kogoj, Nataša Knap, Miroslav Petrovec, Mario Poljak, Tatjana Avšič‐Županc, Miša Korva · 2024 · Briefings in Bioinformatics
95. Roles of conserved tryptophans in trimerization of HIV‐1 membrane‐proximal external regions: Implications for virucidal design via alchemical free‐energy molecular simulations
    Steven T. Gossert, Bibek Parajuli, IRWIN M. CHAIKEN, Cameron F. Abrams · 2018 · Proteins Structure Function and Bioinformatics
96. Functional characteristics of the natural polymorphisms of HIV-1 gp41 in HIV-1 isolates from enfuvirtide-naïve Korean patients
    YoungHyun Shin, Cheol‐Hee Yoon, Hyojin Yang, Hoyong Lim, Byeong‐Sun Choi, Sung Soon Kim, Chun Kang · 2016 · Archives of Virology
97. Investigating host-virus interaction mechanism and phylogenetic analysis of viral proteins involved in the pathogenesis
    Ahmad Abu Turab Naqvi, Farah Anjum, Alaa Shafie, Sufian Badar, Abdelbaset Mohamed Elasbali, Dharmendra Kumar Yadav, Md. Imtaiyaz Hassan · 2021 · PLoS ONE
98. Lung Bronchial Epithelial Cells are HIV Targets for Proviral Genomic Integration
    Dinesh Devadoss, Manisha Singh, Arpan Acharya, Kieu Chinh, Palsamy Periyasamy, Marko Manevski, Neerad C. Mishra, Carmen S. Tellez, Sundaram Ramakrishnan, S A Belinsky et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
99. The Level of Cytokeratin 18 in Patients with HIV and Viral Hepatitis C Co-Infection in Latvia
    Oksana Koļesova, Monta Madelāne, Ilze Ekšteina, Aleksandrs Koļesovs, Angelika Krūmiņa, Ludmila Vīksna · 2020 · Proceedings of the Latvian Academy of Sciences Section B Natural Exact and Applied Sciences
100. HIV-1 gp120-CXCR4 recognition probed with synthetic nanomolar affinity D-peptides containing fragments of gp120 V3 loop
     Ruohan Zhu, Qian Meng, Huijun Zhang, Ge Zhang, Lina Huang, Yan Xu, Robert Turner Schooley, Jing An, Ziwei Huang · 2022 · European Journal of Medicinal Chemistry